Company Search:
Advanced Search
Sponsored Links
Addex Therapeutics Company Snapshot
Addex Therapeutics operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Addex Therapeutics with three other pharmaceutical manufacturers in Europe: Oasmia Pharmaceutical AB of Sweden (2015 sales of 2.07 million Swedish Kronor [US$235,338.30 ] ), Vicore Pharma Holding AB of Sweden (840,000.00 Swedish Kronor [US$95,499.60 ] ), and Merrion Pharmaceuticals Plc which is based in Ireland (620,994.00 Euro [US$671,344.19 ] of which 100% was Pharmaceuticals).

Sales Analysis. Addex Therapeutics reported sales of 392,015.00 Swiss Francs (US$394.38 thousand) for the year ending December of 2015. This represents a sharp decrease of 46.0% versus 2014, when the company's sales were 726,568.00 Swiss Francs.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Addex Therapeutics
  Stock Performance Chart for Addex Therapeutics
  Stock Data: Recent Stock Performance:
  Current Price (3/17/2017): 2.44
(Figures in Swiss Francs)
1 Week 4.3%   13 Weeks 8.9%  
4 Weeks 29.1%   52 Weeks -12.5%  
Addex Therapeutics Key Data:
  Ticker: ADXN Country: Switzerland
  Exchanges: ZHR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 392,015
(Year Ending Jan 2016).
Employees: 8
  Currency: Swiss Francs Market Cap: 27,744,359
  Fiscal Yr Ends: December Shares Outstanding: 11,370,639
  Share Type: Namenaktie Closely Held Shares: 188,364
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.